Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ECULIZUMAB Cause Peritonitis bacterial? 16 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Peritonitis bacterial have been filed in association with ECULIZUMAB (SOLIRIS). This represents 0.0% of all adverse event reports for ECULIZUMAB.

16
Reports of Peritonitis bacterial with ECULIZUMAB
0.0%
of all ECULIZUMAB reports
6
Deaths
14
Hospitalizations

How Dangerous Is Peritonitis bacterial From ECULIZUMAB?

Of the 16 reports, 6 (37.5%) resulted in death, 14 (87.5%) required hospitalization, and 2 (12.5%) were considered life-threatening.

Is Peritonitis bacterial Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ECULIZUMAB. However, 16 reports have been filed with the FAERS database.

What Other Side Effects Does ECULIZUMAB Cause?

Fatigue (4,858) Off label use (4,228) Haemoglobin decreased (3,028) Headache (2,699) Death (2,221) Pyrexia (1,948) Dyspnoea (1,819) Asthenia (1,732) Drug ineffective (1,644) Nausea (1,579)

What Other Drugs Cause Peritonitis bacterial?

CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (4,672) CALCIUM\ICODEXTRIN\MAGNESIUM\SODIUM\SODIUM (804) DIANEAL LOW (461) RIBAVIRIN (134) EXTRANEAL (110) TACROLIMUS (92) CALCIUM\DEXTROSE\HYDROCHLORIC ACID\MAGNESIUM\SODIUM BICARBONATE\SODIUM\SODIUM HYDROXIDE\SODIUM (86) SOFOSBUVIR (85) CALCIUM\DEXTROSE\MAGNESIUM\SODIUM (53) ICODEXTRIN (51)

Which ECULIZUMAB Alternatives Have Lower Peritonitis bacterial Risk?

ECULIZUMAB vs EDARAVONE ECULIZUMAB vs EDETATE ECULIZUMAB vs EDOXABAN ECULIZUMAB vs EDOXABAN TOSILATE ECULIZUMAB vs EFALIZUMAB

Related Pages

ECULIZUMAB Full Profile All Peritonitis bacterial Reports All Drugs Causing Peritonitis bacterial ECULIZUMAB Demographics